MedTech Europe has 103 disclosed EU lobbying meetings from 2024-09-05 to 2026-05-27: 51 with the European Commission and 52 with Members of the European Parliament. Source: EU Transparency Register no. 433743725252-26, Commission disclosures and MEP declarations. Methodology
MedTech Europe
EU lobbying footprint — who they meet, and on what.
- Register no.
- 433743725252-26 ↗
- Disclosed meetings
- 103 (51 Commission · 52 MEP)
- Period
- 2024-09-05 → 2026-05-27
Declared fields of interest: Budget · Business and industry · Communication · Competition · Consumers · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · Institutional affairs · Public health · Regional policy
Lobbying profile
as declared 2026-01-21- Category
- Trade and business associations
- Legal status
- AISBL
- Declared lobbying cost
- €1,500,000
- Lobbying FTEs
- 2.95
- Members
- 9
At a glance
- Technology9
- Trade8
- Health7
- Social1
- Industry1
- Flora Giorgio9
- Sandra Gallina3
- Jana Dabbelt2
- Marc Lemaitre2
- Olivér Várhelyi2
Disclosed meetings
Newest first, showing the most recent 60 of 103. EC = European Commission, EP = Member of the European Parliament.
- MDR/IVDR Revisionsource ↗
- Cybersecurity Act 2 (CSA2) meetingsource ↗
- 2026-05-07ECJugatx Ortiz González · Cabinet of Executive Vice-President Stéphane SéjournéRevision of the public procurement frameworksource ↗
- MDR revisionsource ↗
- 2026-04-16ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-03-19ECMarc Lemaitre · Director-GeneralNext generation of European public-private partnerships under FP10 / Horizon Europesource ↗
- Medical Devices Regulationsource ↗
- Health policysource ↗
- 2026-02-17ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiMedical devices reformsource ↗
- Simplification MDR/IVDRsource ↗
- 2026-02-06ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiCompetitiveness and overlapping regulationssource ↗
- 2026-02-04ECFlora Giorgio · Head of UnitExchange of views on the state of play and next steps for the medical devices sectorsource ↗
- Dispositifs médicauxsource ↗
- Digital Omnibussource ↗
- 2026-01-27ECDenis Redonnet · Deputy Director-GeneralLatest global economic developmentssource ↗
- Digital omnibussource ↗
- Medical devicessource ↗
- Medical Devices and Sustainibilitysource ↗
- Medical technologies industry and trade in Ireland and Europesource ↗
- Echange sur les marchés publicssource ↗
- Health policiessource ↗
- Digital Simplification Package and its effects on Europe´s medical tech sectorsource ↗
- 2026-01-15ECMaria Pilar Aguar Fernandez · DirectorExchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
- 2026-01-15ECCarmen Laplaza Santos · Head of UnitExchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
- 2026-01-12ECFlora Giorgio · Head of UnitExchange of views on the state of play of the medical devices Regulations reform proposal and follow-up on relevant events.source ↗
- Health policysource ↗
- 2025-12-04ECAxel Hellman · Cabinet of Commissioner Jessika RoswallEnvironmental legislation and medical technologysource ↗
- AMRsource ↗
- Medical devicessource ↗
- One Healthsource ↗
- 2025-11-18ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiMedical device reviewsource ↗
- 2025-11-12ECFlora Giorgio · Head of UnitFollow-up meeting at the request of MTE to further discuss the technical input provided in the context of short-term measures and to exchange views on the upcoming MDR/IVDR reform.source ↗
- 2025-11-07ECWerner Stengg · Cabinet of Executive Vice-President Henna VirkkunenDigital Omnibussource ↗
- Impact of US tariffs on medical technology companiessource ↗
- Health Policysource ↗
- 2025-09-25ECChiara Galiffa · Cabinet of Commissioner Maroš ŠefčovičEU – US relationssource ↗
- 2025-09-23ECSaila Rinne · Head of UnitAI in health.source ↗
- 2025-09-23ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiPreparation for the upcoming EU Cardiovascular Action Plansource ↗
- 2025-09-23ECPatricia Reilly · Cabinet of President Ursula von der LeyenEU Cardiovascular Health Plan & Medical Devices Regulation (MDR)source ↗
- EU Health Policysource ↗
- Cardiovascular diseasessource ↗
- Cardiovascular Healthsource ↗
- cardiovasculairesource ↗
- 2025-09-04ECLucilla Sioli · DirectorImplementation of the AI Actsource ↗
- Austauschsource ↗
- 2025-07-24ECMaya Matthews · Head of UnitDiscuss the input received during the public feedback on the draft Implementing Regulation on joint clinical assessments for medical devices and in vitro diagnostic medical devicessource ↗
- 2025-07-18ECWerner Stengg · Cabinet of Executive Vice-President Henna VirkkunenArtificial Intelligencesource ↗
- 2025-07-10ECMarco Marsella · DirectorEHDS and IHI callssource ↗
- Intro Meetingsource ↗
- Health policysource ↗
- 2025-06-30ECSandra Gallina · Director-GeneralCardiovascular health and the EU Medical Devices legislationsource ↗
- 2025-06-30ECCristina Modoran · Head of UnitCardiovascular health and the EU Medical Devices legislationsource ↗
- 2025-06-30ECFlora Giorgio · Head of UnitCardiovascular health and the EU Medical Devices legislationsource ↗
- 2025-06-24ECSandra Gallina · Director-GeneralEU medical device regulation and policy.source ↗
- 2025-06-24ECCristina Modoran · Head of UnitEU medical device regulation and policy.source ↗
- 2025-06-24ECFlora Giorgio · Head of UnitExchange of views on the state of play and next steps for the medical devices sector.source ↗
- 2025-06-24ECRainer Becker · DirectorEU medical device regulation and policy.source ↗
- 2025-06-24ECSandra Gallina · Director-GeneralExchange of views on the state of play and next steps for the medical devices sector.source ↗
- 2025-06-23ECEkaterina Zaharieva · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2025-06-20ECPatricia Reilly · Cabinet of President Ursula von der LeyenMedical technology tariffs and tradesource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has MedTech Europe disclosed?
MedTech Europe (EU Transparency Register no. 433743725252-26) appears in 103 disclosed meetings with EU officials and MEPs between 2024-09-05 and 2026-05-27: 51 with the European Commission and 52 with Members of the European Parliament.
What does MedTech Europe lobby on?
MedTech Europe's disclosed EU meetings most often concern Technology, Trade, Health, Social. Every meeting and its topic is listed with its official source on this page.
Who does MedTech Europe meet in Brussels?
Across its disclosed meetings, MedTech Europe has met Commission officials including Flora Giorgio, Sandra Gallina, Jana Dabbelt, and MEPs including SOKOL Tomislav, GLÜCK Andreas, KULJA András Tivadar. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 433743725252-26) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.